Pfizer boosts full-year guidance on the back of its latest quarter, citing growth in non-Covid offerings and acquired products.
Yahoo
Skip to navigation
Skip to main content
Skip to right column
Pfizer CEO Says Covid Is ‘Irrelevant.’ He’s Betting on Cancer and Weight-Loss Drugs. ·
Barrons.com
·
Amir Hamja/Bloomberg
